Sexual and reproductive health

Contraceptive eligibility for women at high risk of HIV

Guidance statement - Recommendations on contraceptive methods used by women at high risk of HIV

Authors:
WHO

Image of front cover

Publication details

Number of pages: 24
Publication date: 2019
Languages: English
ISBN: 978-92-4-155057-4

Downloads

The World Health Organization (WHO) convened a Guideline Development Group (GDG) meeting from 29 to 31 July 2019 to review global guidance on contraceptive eligibility for women at high risk of HIV acquisition to and determine whether revisions to the fifth edition of the Medical eligibility criteria for contraceptive use (MEC) were needed. The issue was deemed critical, particularly for sub-Saharan Africa, given the high lifetime risk of acquiring HIV alongside the importance of hormonal contraception in offering women and adolescent girls’ choice and in reducing their risk of unintended pregnancy, a common threat to the health, well-being and lives of women and adolescent girls.

The GDG consisted of 28 participants from 19 countries, including experts in family planning and HIV, representatives from affected populations, clinicians, epidemiologists, researchers, programme managers, policy-makers and guideline methodologists.

Related documents